Welcome to our dedicated page for Lifeway Food SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Lifeway Foods, Inc. (NASDAQ: LWAY), an Illinois-based manufacturer of probiotic, cultured and fermented dairy foods. Through these filings, investors can review how the company reports financial performance, governance changes and key agreements that affect LWAY common stock.
Recent Form 8-K current reports document a range of material events. One 8-K dated November 12, 2025 furnishes five-year financial projections that Lifeway provided to Danone North America PBC during due diligence for a potential transaction, including net sales, gross profit, operating income, Adjusted EBITDA, capital expenditures and free cash flow. Other 8-Ks disclose estimated unaudited net sales for a fiscal quarter, the execution of a Cooperation Agreement with Danone, the appointment and resignation of directors, and the scheduling of annual shareholder meetings.
Filings also describe governance and rights arrangements. An 8-K dated October 29, 2025 outlines Amendment No. 1 to the Shareholder Rights Agreement, extending the expiration of a shareholder rights plan and explaining the board’s rationale related to concentrated share ownership and potential accumulation of control without a premium. Another 8-K filed September 30, 2025 details the Cooperation Agreement with Danone, including board refreshment, voting commitments and registration rights for Danone’s holdings.
On Stock Titan, Lifeway’s SEC filings are updated in step with the EDGAR system and paired with AI-powered summaries that explain the significance of each document in clear language. Users can quickly scan 8-K disclosures for governance and transaction developments, and refer to annual and quarterly reports when available for a broader view of Lifeway’s financial condition and risk factors, without having to interpret every technical section themselves.
Divisadero Street Capital Management and related entities filed an amended Schedule 13G reporting passive ownership of Lifeway Foods, Inc. common stock. They report beneficial ownership of 1,347,635 shares, equal to 8.9% of Lifeway’s common stock as of 12/31/2025, with shared voting and dispositive power over all reported shares.
The filing explains that all securities are directly owned by advisory clients of Divisadero Street Capital Management, including Divisadero Street Partners, L.P., and that the reporting persons disclaim beneficial ownership beyond their pecuniary interests. They also certify the position is not held for the purpose of influencing control of Lifeway Foods.
Lifeway Foods, Inc. CFO Eric A. Hanson reported equity award activity and updated holdings. On January 10, 2026, restricted stock units converted into 3,751 shares of common stock, increasing his directly held shares to 45,384. The filing shows that 1,720 shares were then surrendered to the company for tax withholding, rather than sold in the market, leaving 43,664 common shares held directly.
The report also details multiple restricted stock unit grants. One grant covers 2,390 RSUs scheduled to vest on June 16, 2026 if he remains in service. Another includes units of which 1,261 RSUs are scheduled to vest on January 10, 2027 under continued service conditions. A further grant of 2,228 RSUs is structured to vest in three equal steps in March 2026, 2027, and 2028, again contingent on continued service.
Lifeway Foods director Dorri McWhorter reported equity award activity involving restricted stock units and common shares. On January 10, 2026, 3,151 shares of Lifeway Foods common stock were acquired following the vesting and settlement of previously granted restricted stock units, bringing her directly held common stock to 25,936 shares.
The filing also shows she continues to hold 2,512 restricted stock units scheduled to vest on December 30, 2026, and 2,710 restricted stock units scheduled to vest in two installments on July 1, 2026 and July 1, 2027, all contingent on her continued service as a director.
Lifeway Foods, Inc. director Juan Carlos Dalto reported equity award activity and deferral elections rather than an open-market stock sale. On January 10, 2026, previously vested restricted stock units (RSUs) totaling 3,151 units were converted into an equal number of phantom stock shares under the company’s 2022 Non-Employee Director Equity and Deferred Compensation Plan, to be paid when he no longer serves as a director.
Following these transactions, Dalto beneficially owns 4,751 shares of common stock directly, along with 2,512 RSUs scheduled to vest on December 30, 2026, and 2,710 RSUs that are scheduled to vest in tranches on July 1, 2026 and July 1, 2027, subject to continued service. He also holds 6,586 shares of phantom stock, each representing a right to receive one share of common stock in the future.
Lifeway Foods director Jason Scott Scher reported equity award activity and a deferral election. On January 10, 2026, previously granted restricted stock units (RSUs) that had vested earlier were settled, with 1,600 RSUs and 1,551 RSUs converted in connection with prior vesting dates. Instead of receiving common stock, Scher deferred the settlement under the company’s 2022 Non-Employee Director Equity and Deferred Compensation Plan and received 3,151 shares of phantom stock, each linked to one share of common stock and payable when he no longer serves as a director. He continues to hold RSUs scheduled to vest in 2026 and 2027, as well as phantom stock and a small direct common share position.
Lifeway Foods, Inc. reported that it expects net sales for the year ended December 31, 2025 to be between
Edward Smolyansky, a major Lifeway Foods shareholder and board nominee, outlines his campaign ahead of the 2025 shareholder vote. He asks investors to back himself and George Sent as “Shareholder Nominees” by voting on the GREEN card, support Proposal 6 to create an independent Strategic Review & Performance Committee, and withhold votes from Julie Smolyansky, Dorri McWhorter, and Jason Scher.
Smolyansky says that, as co‑founders and large owners, he and Ludmila Smolyansky have spent years challenging what they view as weak governance, including the handling of unsolicited acquisition interest from Danone at $25 and $27 per share. He criticizes board-approved compensation decisions, citing an issuance of 283,337 shares and a $2 million retention bonus on top of equity grants valued at more than $6.5 million, and raises concerns about nepotism, director independence, and oversight of executive pay. He argues that electing his slate would enable a credible strategic review and tighter governance.